0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.77%
5Y CAGR of 0.77% while NHC.AX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
2.46%
3Y revenue/share CAGR under 50% of NHC.AX's 135.53%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
359.87%
10Y OCF/share CAGR under 50% of NHC.AX's 900.36%. Michael Burry would worry about a persistent underperformance in cash creation.
-33.91%
Negative 5Y OCF/share CAGR while NHC.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
138.76%
3Y OCF/share CAGR under 50% of NHC.AX's 292.35%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
29.54%
Below 50% of NHC.AX's 7738.39%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
957.27%
Net income/share CAGR of 957.27% while NHC.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
298.41%
3Y net income/share CAGR similar to NHC.AX's 278.00%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-89.86%
Negative equity/share CAGR over 10 years while NHC.AX stands at 24.92%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
209.87%
Equity/share CAGR of 209.87% while NHC.AX is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1153.54%
3Y equity/share CAGR above 1.5x NHC.AX's 40.72%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6126955.88%
3Y dividend/share CAGR above 1.5x NHC.AX's 573.00%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.